Company intelligence / Profile preview

Rongchang Pharmaceuticals

Yantai, Shandong, Chinarongchang.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Rongchang Pharmaceuticals is a leading Chinese pharmaceutical conglomerate with a focus on modern traditional Chinese medicine, small molecule drugs, biologics—including mAbs and ADCs—and contract manufacturing. Its subsidiary RemeGen has achieved commercial approval for telitacicept for SLE in China and disitamab vedotin for gastric cancer. The group maintains a robust late-stage clinical pipeline targeting oncology, autoimmune diseases, and ophthalmology.

Therapeutic areas
OncologyOphthalmologyImmunology
Modalities
Small moleculesMonoclonal antibodies (mAbs)Antibody-drug conjugates (ADCs)Fusion proteinsBispecific antibodies
Industry
Biotech
02

Drug pipeline

4 assets

RCZY-711

Preclinical

3 more assets in the full pipeline.

Request access →
03

Partnerships

Not explicitly listed but likely includes global licensing/commercialization partners through its subsidiary programs.

Beyond the preview

Go deeper on Rongchang Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rongchang Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call